Wow looking at these patents it brings more fear into my heart. That these broad patents almost failed to be passed. In fact, 3 of these are essentially repeats. Whilst the others are intrinsically broad. I’m glad VT’s trial and error has awarded two real patents. Let’s keep it up, maybe the third one will be a patent on using natively produced FGF-1! This is a scary company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.